Mar 07, 2019
The researchers undertook the study to better understand oncologic and toxicity outcomes from a combined approach to treatment. | Read More
Feb 28, 2019
Patients with advanced biliary tract cancer may potentially be treated with tremelimumab in combination with microwave ablation, according to a pilot study. | Read More
Feb 26, 2019
Researchers assessed the efficacy and safety of Y-90 in 33 patients with metastatic pancreatic adenocarcinoma. | Read More
Feb 22, 2019
DOSIsoft, leading provider of advanced software solutions for Radiation Oncology and Nuclear Medicine, is pleased to announce it has received on March 7th, 2019, from the US Food and Drug Administration (FDA), the 510(k) clearance to market PLANET® Onco Dose software, for its Oncology and Yttrium-90 microsphere SIRT 3D Dosimetry components. | Read More
Feb 21, 2019
To investigate the feasibility of SABR, investigators prospectively recruited 147 patients with oligometastatic cancer to the study. | Read More
Feb 14, 2019
Researchers have developed a prognostic score that can help to stratify candidates for transarterial chemoembolization (TACE), according to a study published in the Journal of Hepatology. | Read More
Feb 12, 2019
Patients with hepatocellular carcinoma and gross vascular invasion may have improved overall survival after being treated with dual modality radiation with external beam radiation therapy (EBRT) and transarterial radioembolization (TARE). | Read More
Feb 07, 2019
Results of a phase II trial suggest that image-guided high-dose-rate (HDR) brachytherapy (iBT) may lead to better outcomes than conventional transarterial embolization (cTACE) in treating unresectable hepatocellular carcinoma (HCC). | Read More
Feb 04, 2019
Patients with renal cell carcinoma who were treated with a combination of sorafenib and cryoablation were compared with those who were treated with sorafenib alone. | Read More
Jan 25, 2019
Primary malignant tumors comprise only 1% to 2% of childhood cancers, but alternatives are still needed for patients in whom chemotherapy fails. | Read More